ASX - By Stock
|
IPD |
Re:
Ann: Notification of Quarterly Results & Investor, Revised
|
|
Roger10
|
26 |
8.4K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
26
|
8.4K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
Roger10
|
135 |
49K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
135
|
49K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
Roger10
|
135 |
49K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
135
|
49K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - March-2024 Qtr
|
|
Roger10
|
8 |
2.2K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
8
|
2.2K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Q2 predictions?
|
|
Roger10
|
55 |
17K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
55
|
17K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Q2 predictions?
|
|
Roger10
|
55 |
17K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
55
|
17K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
758
|
343K
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
758
|
343K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
758
|
343K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
Roger10
|
135 |
49K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
135
|
49K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Roger10
|
1.5K |
563K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
758
|
343K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
758
|
343K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Roger10
|
1.5K |
563K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix to Acquire ARTMS (Isotope Production Platform)
|
|
Roger10
|
43 |
17K |
13 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
43
|
17K
|
13
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK agrees to scheme agreement with PAR Technology
|
|
Roger10
|
62 |
22K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
62
|
22K
|
1
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK agrees to scheme agreement with PAR Technology
|
|
Roger10
|
62 |
22K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
62
|
22K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Revised Change of Director's Interest Notice-Mr A Grant
|
|
Roger10
|
5 |
1.5K |
1 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
5
|
1.5K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Revised Change of Director's Interest Notice-Mr A Grant
|
|
Roger10
|
5 |
1.5K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
5
|
1.5K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 2023 Full Year Results Presentation
|
|
Roger10
|
30 |
10K |
10 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
30
|
10K
|
10
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Roger10
|
130 |
42K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
42K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Roger10
|
130 |
42K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
130
|
42K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Roger10
|
130 |
42K |
5 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
130
|
42K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Presentation to Accompany QSAM Acquisition
|
|
Roger10
|
23 |
12K |
6 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
23
|
12K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Roger10
|
280 |
59K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
280
|
59K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Roger10
|
280 |
59K |
8 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
280
|
59K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Roger10
|
280 |
59K |
12 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
280
|
59K
|
12
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Roger10
|
280 |
59K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
280
|
59K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
5 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
758
|
343K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Roger10
|
758 |
343K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
758
|
343K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Composition of Board and Committees
|
|
Roger10
|
8 |
2.3K |
3 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Q2 predictions?
|
|
Roger10
|
55 |
17K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
55
|
17K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference Presentation
|
|
Roger10
|
62 |
24K |
1 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
62
|
24K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference Presentation
|
|
Roger10
|
62 |
24K |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
62
|
24K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
trading is changing .....
|
|
Roger10
|
28 |
7.0K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
28
|
7.0K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
|
|
Roger10
|
89 |
23K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
89
|
23K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
THE PROPOSED DIRECTORS SPEAK ....
|
|
Roger10
|
12 |
3.1K |
2 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
12
|
3.1K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Market Update - Executing Towards Profitability in Oncology
|
|
Roger10
|
117 |
29K |
5 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
117
|
29K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: First Top 5 National Payor Covering SOZO Testing
|
|
Roger10
|
29 |
10K |
10 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
29
|
10K
|
10
|
|
ASX - By Stock
|
IPD |
Re:
Ann: First Published Medical Policy for Bioimedance Spectroscopy
|
|
Roger10
|
18 |
6.4K |
4 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
18
|
6.4K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: First Published Medical Policy for Bioimedance Spectroscopy
|
|
Roger10
|
18 |
6.4K |
7 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
18
|
6.4K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Roger10
|
195 |
65K |
6 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
195
|
65K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: SOZO Pro Achieves Clearance by U.S. FDA
|
|
Roger10
|
30 |
10K |
5 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
30
|
10K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs
|
|
Roger10
|
67 |
27K |
7 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
67
|
27K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Presents at H.C. Wainwright BioConnect Conference
|
|
Roger10
|
7 |
3.5K |
1 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
7
|
3.5K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Presents at H.C. Wainwright BioConnect Conference
|
|
Roger10
|
7 |
3.5K |
0 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
7
|
3.5K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Awarded A$8.8M Aust Govt Grant for Sarcoma Trial
|
|
Roger10
|
9 |
3.2K |
6 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
9
|
3.2K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda and Opdivo IONIC Study First Patient Dosed
|
|
Roger10
|
37 |
13K |
1 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: June 2021 Quarterly Activities Report and Appendix 4C
|
|
Roger10
|
10 |
3.1K |
5 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
10
|
3.1K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Perspective
|
|
Roger10
|
5 |
1.4K |
1 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|